{"id":9194,"date":"2021-08-11T14:29:40","date_gmt":"2021-08-11T18:29:40","guid":{"rendered":"https:\/\/drealfmgrenada.com\/?p=9194"},"modified":"2021-08-11T14:29:40","modified_gmt":"2021-08-11T18:29:40","slug":"who-mass-testing-three-potential-covid-19-treatments","status":"publish","type":"post","link":"https:\/\/drealfmgrenada.com\/index.php\/2021\/08\/11\/who-mass-testing-three-potential-covid-19-treatments\/","title":{"rendered":"WHO Mass-Testing Three Potential COVID-19 Treatments"},"content":{"rendered":"<p>GENEVA,\u00a0Switzerland\u00a0(AFP) \u2014 The World Health Organization on Wednesday announced major international trials of three drugs to find out whether they improve the condition of hospitalised COVID-19 patients.<\/p>\n<p>Artesunate, imatinib and infliximab will be tested on thousands of volunteer patients in more than 600 hospitals in 52 countries.<\/p>\n<p>&#8220;Finding more effective and accessible therapeutics for COVID-19 patients remains a critical need,&#8221; said WHO director-general Tedros Adhanom Ghebreyesus.<\/p>\n<p>Artesunate is a treatment for severe malaria; imatinib a drug used for certain cancers and infliximab a treatment for immune system disorders such as Crohn&#8217;s and rheumatoid arthritis.<\/p>\n<p>The coordinated research across dozens of countries allows the trial to assess multiple treatments using a single protocol, thereby generating robust estimates on the effect a drug may have on mortality, including moderate effects, said the WHO.<\/p>\n<p>The drugs were chosen by an independent expert panel for their potential in reducing the risk of death in hospitalised COVID-19 patients.<\/p>\n<p>They were donated for the trial by their manufacturers and are already being shipped out to the hospitals involved.<\/p>\n<div id=\"taboola-mid-article-reco-reel\" class=\" trc_related_container trc_spotlight_widget\"><\/div>\n<p>&#8211; Previous trial&#8217;s dead end &#8211;<\/p>\n<p>The testing of artesunate, imatinib and infliximab on COVID-19 patients is the second stage of the WHO&#8217;s Solidarity hunt for effective treatments against the killer disease.<\/p>\n<p>Previously, four drugs were evaluated by the Solidarity trial, involving almost 13,000 patients in 500 hospitals across 30 countries.<\/p>\n<p>The provisional results issued in October showed that remdesivir, hydroxychloroquine, lopinavir and interferon had little or no effect on hospitalised patients with COVID-19.<\/p>\n<p>The final results are due out next month.<\/p>\n<p>&#8220;We already have many tools to prevent, test for and treat COVID-19, including oxygen, dexamethasone and IL-6 blockers. But we need more, for patients at all ends of the clinical spectrum, from mild to severe disease,&#8221; Tedros told a news conference.<\/p>\n<p>The WHO COVID-19 Therapeutics Advisory Group recommended evaluating the anti-inflammatory properties of artesunate, which has been extensively used in the treatment of malaria and other parasitic diseases for more than 30 years, and is regarded as being very safe.<\/p>\n<p>A randomised clinical trial in the Netherlands reported that imatinib, a small molecule tyrosine kinase inhibitor, might confer clinical benefit in hospitalised COVID-19 patients.<\/p>\n<p>Meanwhile, infliximab has shown favourable efficacy and safety in restricting broad spectrum inflammation, including in the elderly populations who are the most clinically vulnerable to COVID-19.<\/p>\n<p>&#8211; 300 million cases warning &#8211;<\/p>\n<p>The novel coronavirus has killed at least 4.3 million people since the outbreak emerged in China in December 2019, according to a tally from official sources compiled by AFP, while nearly 204 million cases have been registered.<\/p>\n<p>Lamenting that the 200 millionth known case came just six months after the 100 millionth, Tedros said the real number of cases was &#8220;much higher&#8221;.<\/p>\n<p>&#8220;Whether we reach 300 million, and how fast we get there, depends on all of us,&#8221; the UN health agency chief said.<\/p>\n<p>&#8220;At the current trajectory, we could pass 300 million reported cases early next year. But we can change that. We&#8217;re all in this together, but the world is not acting like it.&#8221;<\/p>\n<p>The WHO has consistently decried the drastic imbalance between rich and poor countries in access to COVID-19 vaccines.<\/p>\n<div class=\"tbl-read-more-box\"><\/div>\n","protected":false},"excerpt":{"rendered":"<div class=\"mh-excerpt\"><p>GENEVA,\u00a0Switzerland\u00a0(AFP) \u2014 The World Health Organization on Wednesday announced major international trials of three drugs to find out whether they improve the condition of hospitalised COVID-19 patients. Artesunate, imatinib and infliximab will be tested on <a class=\"mh-excerpt-more\" href=\"https:\/\/drealfmgrenada.com\/index.php\/2021\/08\/11\/who-mass-testing-three-potential-covid-19-treatments\/\" title=\"WHO Mass-Testing Three Potential COVID-19 Treatments\">[&#8230;]<\/a><\/p>\n<\/div>","protected":false},"author":1,"featured_media":9195,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[45],"tags":[],"class_list":{"0":"post-9194","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health"},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?fit=1024%2C683&ssl=1","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"rttpg_featured_image_url":{"full":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?fit=1024%2C683&ssl=1",1024,683,false],"landscape":["https:\/\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg",1024,683,false],"portraits":["https:\/\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg",1024,683,false],"thumbnail":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?resize=150%2C150&ssl=1",150,150,true],"medium":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?fit=300%2C200&ssl=1",300,200,true],"large":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?fit=1024%2C683&ssl=1",1024,683,true],"1536x1536":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?fit=1024%2C683&ssl=1",1024,683,true],"2048x2048":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?fit=1024%2C683&ssl=1",1024,683,true],"mh-magazine-slider":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?resize=1024%2C438&ssl=1",1024,438,true],"mh-magazine-content":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?resize=678%2C381&ssl=1",678,381,true],"mh-magazine-large":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?resize=678%2C509&ssl=1",678,509,true],"mh-magazine-medium":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?resize=326%2C245&ssl=1",326,245,true],"mh-magazine-small":["https:\/\/i0.wp.com\/drealfmgrenada.com\/wp-content\/uploads\/2021\/08\/AR-210819935.jpg?resize=80%2C60&ssl=1",80,60,true]},"rttpg_author":{"display_name":"adminrfm","author_link":"https:\/\/drealfmgrenada.com\/index.php\/author\/adminrfm\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/drealfmgrenada.com\/index.php\/category\/health\/\" rel=\"category tag\">Health<\/a>","rttpg_excerpt":"GENEVA,\u00a0Switzerland\u00a0(AFP) \u2014 The World Health Organization on Wednesday announced major international trials of three drugs to find out whether they improve the condition of hospitalised COVID-19 patients. Artesunate, imatinib and infliximab will be tested on [...]","_links":{"self":[{"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/posts\/9194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/comments?post=9194"}],"version-history":[{"count":1,"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/posts\/9194\/revisions"}],"predecessor-version":[{"id":9196,"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/posts\/9194\/revisions\/9196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/media\/9195"}],"wp:attachment":[{"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/media?parent=9194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/categories?post=9194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drealfmgrenada.com\/index.php\/wp-json\/wp\/v2\/tags?post=9194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}